Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CICCIA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.699
EU - Europa 7.700
AS - Asia 6.332
SA - Sud America 1.037
AF - Africa 157
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 6
Totale 30.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.495
SG - Singapore 2.320
RU - Federazione Russa 1.983
IT - Italia 1.819
CN - Cina 1.738
DE - Germania 843
BR - Brasile 841
FI - Finlandia 800
HK - Hong Kong 686
VN - Vietnam 561
UA - Ucraina 412
PL - Polonia 407
GB - Regno Unito 354
FR - Francia 310
IE - Irlanda 248
JP - Giappone 211
SE - Svezia 149
BD - Bangladesh 146
KR - Corea 142
IN - India 128
CA - Canada 102
NL - Olanda 78
RO - Romania 73
AR - Argentina 62
MX - Messico 59
IQ - Iraq 57
TR - Turchia 57
BE - Belgio 41
ES - Italia 41
ZA - Sudafrica 39
AT - Austria 34
ID - Indonesia 32
AU - Australia 31
EC - Ecuador 27
PK - Pakistan 27
CO - Colombia 25
VE - Venezuela 24
EG - Egitto 23
UZ - Uzbekistan 23
CH - Svizzera 22
CL - Cile 20
AE - Emirati Arabi Uniti 19
PH - Filippine 19
PY - Paraguay 19
IR - Iran 18
MY - Malesia 18
JO - Giordania 17
SA - Arabia Saudita 17
CZ - Repubblica Ceca 16
KE - Kenya 16
CI - Costa d'Avorio 14
DZ - Algeria 14
MA - Marocco 14
GR - Grecia 13
NP - Nepal 13
LB - Libano 12
LT - Lituania 12
AZ - Azerbaigian 10
TW - Taiwan 10
BO - Bolivia 9
PA - Panama 9
TN - Tunisia 9
CR - Costa Rica 8
GE - Georgia 8
IL - Israele 8
KG - Kirghizistan 8
ET - Etiopia 7
DK - Danimarca 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
SN - Senegal 5
UY - Uruguay 5
AL - Albania 4
BG - Bulgaria 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
EU - Europa 4
HN - Honduras 4
MD - Moldavia 4
OM - Oman 4
BB - Barbados 3
JM - Giamaica 3
MU - Mauritius 3
PE - Perù 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
GA - Gabon 2
GD - Grenada 2
HR - Croazia 2
KW - Kuwait 2
LU - Lussemburgo 2
LV - Lettonia 2
PR - Porto Rico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 30.937
Salva come PNG Salva come JPEG
Città #
Fairfield 1.913
Ashburn 1.865
Singapore 1.640
Woodbridge 984
Seattle 817
Chandler 773
Wilmington 759
Houston 707
San Jose 698
Hong Kong 641
Cambridge 612
Ann Arbor 513
Moscow 389
Zgierz 356
Secaucus 341
Palermo 315
Des Moines 292
Los Angeles 291
Beijing 275
Council Bluffs 271
Helsinki 253
Medford 251
Dublin 245
Dallas 211
Jacksonville 202
Santa Clara 198
Tokyo 195
New York 188
Ho Chi Minh City 178
Chicago 169
Nanjing 167
Altamura 162
Lauterbourg 162
Princeton 161
Hefei 149
Frankfurt am Main 142
San Diego 137
Hanoi 133
Boardman 128
Lawrence 124
The Dalles 114
Milan 108
Jinan 90
Dearborn 82
Buffalo 79
Rome 71
Shenyang 69
São Paulo 64
Ludwigshafen am Rhein 63
Tulsa 60
Nanchang 59
London 53
Seoul 47
Phoenix 46
Tianjin 46
Changsha 45
Hebei 45
Zhengzhou 43
Warsaw 42
Brussels 40
Orem 39
Jiaxing 36
Da Nang 35
Guangzhou 34
Amsterdam 32
Seongnam 31
Columbus 30
Ningbo 30
Munich 29
Toronto 29
Johannesburg 28
Rio de Janeiro 28
Atlanta 27
Bologna 26
Salt Lake City 26
Boston 25
Montreal 25
Naples 25
Falls Church 24
Haiphong 24
Kumar 24
San Paolo di Civitate 24
Baghdad 23
Brooklyn 23
Poplar 23
Denver 22
Saint Petersburg 22
Venice 22
Hangzhou 20
Nuremberg 20
Pune 20
Belo Horizonte 19
Central 19
Stockholm 19
Taizhou 19
Verona 19
Kilburn 18
Manchester 18
Tampa 18
Mumbai 17
Totale 20.265
Salva come PNG Salva come JPEG
Nome #
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 1.076
Malattia di KiKuchi-Fujimoto e lupus eritematoso sistemico: quale connessione ?. 513
Intestinal Involvement in Kawasaki Disease 341
Ectopic expression of CXCL13, BAFF, APRIL and LT-ß is associated with artery tertiary lymphoid organs in giant cell arteritis 310
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 291
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs 285
Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response 284
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis 282
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 281
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. 278
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity. 277
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 275
Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: A prospective open-label study 274
Associazione tra spondiloartrite e gammopatia monoclonale: tre casi clinici 259
Downregulation of miRNA17-92 cluster marks Vγ9Vδ2 T cells from patients with rheumatoid arthritis 257
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 256
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis 254
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 252
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 245
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 242
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis 241
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. 238
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes 238
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 237
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 237
New insights into the pathogenesis of giant cell arteritis 236
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 235
Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. 233
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 233
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 232
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 228
Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome 228
Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients. 226
Atherosclerosis in female patients with rheumatoid arthritis: a two years of follow up 224
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 224
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease 223
IL-17 polarization of MAIT cells is derived from the activation of two different pathways 222
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis 220
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis 220
La determinazione degli anticorpi anti-peptide ciclico citrullinato è utile nel discriminare pazienti con artrite reumatoide da quelli con poliartrite associata a tiroidite cronica autoimmune 219
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 219
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 219
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis 217
Arteriosclerosi ed artrite reumatoide: ruolo della terapia biologica 214
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients 213
Atherosclerosis in females patients with rheumatoid arthritis; a two years follow-up. 210
Ruolo della terapia con aspirina e con immunoglobuline endovena nella poliabortività associata a sindrome da anticorpi anti-fosfolipidi 207
Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA–B27 Activates the Unfolded Protein Response 207
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 203
Atherosclerosis in female patients with rheumatoid arthritis; a two years follow-up 201
Pro-inflammatory CX3CR1+ CD59+ TL1A+ IL-23+ monocytes are expanded in patients with Ankylosing Spondylitis and modulate ILC3 immune functions 201
Aterosclerosi e artrite reumatoide: ruolo della twerapia biologica 198
IVIG in APS pregnancy 196
Brief Report: Intestinal dysbiosis in ankylosing spondylitis 196
An intense physical rehabilitation program determines pain relief and improves the global quality of life in patients with fibromyalgia 195
Exosomes as Intercellular Signaling Organelles Involved in Health and Disease: Basic Science and Clinical Applications 193
T2-mapping of the sacroiliac joints at 1.5 Tesla: a feasibility and reproducibility study 193
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. 191
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 191
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 191
Disfunzione diastolica in pazienti affetti da artrite reumatoide: ruolo della terapia con anti-TNFα 190
Impatto del trattamento precoce con infliximab + methotrexate ed alte dosi di prednisone (PDN) vs infliximab (IFX) + methotrexate (MTX) e basse dosi di steroide nella very early rheumatoid arthritis (VERA): contributo casistico 188
Disfunzione diastolica in pazienti affetti da artrite reumatoide:ruolo della terapia con anti-TNF 188
AUTOPHAGY, BUT NOT THE UNFOLDED PROTEIN RESPONSE, REGULATES THE EXPRESSION OF IL-23 IN THEGUT OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND SUBCLINICAL GUT INFLAMMATION 187
Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome. 186
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 186
Artropatia sclerodermica ed artrite reumatoide: non evidenza di overlap 185
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases 184
Pathogenesis of polymyalgia rheumatica 184
Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue 182
Subclinical gut inflammation in ankylosing spondylitis 179
Giant cell arteritis associated with chronic active Epstein-Barr virus infection. 178
pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease 178
Rapida induzione di remissione di un caso di malattia di Vogt-Koyonagi-Harada recidivante dopo terapia con infliximab 177
Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis 175
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 175
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 175
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 174
IBD e malattie reumatiche. Malattia di Crohn e spondilite anchilosante: una patogenesi comune? 173
Iniezione locale di infliximab nel trattamento della dattilite 171
Athersoclerosis in females patients with rheumatoid arthritis: a two years follow-up 171
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 171
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. 170
Interleukin-9 and T helper type 9 cells in rheumatic diseases 170
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 169
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 169
THE LEVEL OF SOLUBLE GRANZYME A IS ELEVATED IN THE PLASMA AND IN THE Vgamma9/Vdelta2 T CELL CULTURE SUPERNATANTS OF PATIENTS WITH ACTIVE BEHCET'S DISEASE 168
Profilo citochinico ed espressione di STATS e SOCS nell’intestino di pazienti affetti da spondilite anchilosante 168
Micofenolato mofetil nell’alveolite sclerodermica: uno studio pilota 166
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 166
Invariant NKT cells and rheumatic disease: Focus on primary sjogren syndrome 166
Diastolic dysfunction in patients with rheumatoid arthritis treated with TNF blocking agents 165
Efficacia e sicurezza di infliximab nelle spondiloartriti indifferenziate: follow-up a 2 anni 163
The level of solubile granzyme A is elevated in the plasma and in the Vγ9/Vδ2 T cell culture supernatants of patients with active Behçet's disease. 163
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 162
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. 162
Impatto del trattamento precoce con infliximab + methotrexate (MTX) ed alte dosi di prednisone (PDN) vs infliximab (IFX)+methotrexate (MTX) e basse dosi di steroide nella very early rheumatoid arthritis (VERA): contributo casistico 161
Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation. 161
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage 161
Primary sjogren syndrome: Focus on innate immune cells and inflammation 160
Totale 22.108
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021247 0 0 0 0 0 0 0 0 0 0 0 247
2021/20221.995 114 382 71 76 56 111 97 143 207 287 129 322
2022/20232.675 276 470 50 251 296 375 242 211 286 37 129 52
2023/20241.187 70 181 73 81 98 247 145 68 24 47 35 118
2024/20253.351 71 220 179 264 125 140 233 220 226 318 415 940
2025/202611.939 749 603 755 1.248 1.144 1.665 1.729 1.147 946 1.348 529 76
Totale 32.125